全文获取类型
收费全文 | 36375篇 |
免费 | 2939篇 |
国内免费 | 1222篇 |
专业分类
耳鼻咽喉 | 50篇 |
儿科学 | 914篇 |
妇产科学 | 485篇 |
基础医学 | 3092篇 |
口腔科学 | 296篇 |
临床医学 | 3321篇 |
内科学 | 8858篇 |
皮肤病学 | 188篇 |
神经病学 | 2309篇 |
特种医学 | 920篇 |
外科学 | 2272篇 |
综合类 | 5347篇 |
现状与发展 | 5篇 |
预防医学 | 2686篇 |
眼科学 | 337篇 |
药学 | 6239篇 |
20篇 | |
中国医学 | 2126篇 |
肿瘤学 | 1071篇 |
出版年
2023年 | 608篇 |
2022年 | 804篇 |
2021年 | 1527篇 |
2020年 | 1334篇 |
2019年 | 1105篇 |
2018年 | 1103篇 |
2017年 | 1114篇 |
2016年 | 1282篇 |
2015年 | 1327篇 |
2014年 | 2211篇 |
2013年 | 2693篇 |
2012年 | 2226篇 |
2011年 | 2188篇 |
2010年 | 1785篇 |
2009年 | 1660篇 |
2008年 | 1694篇 |
2007年 | 1525篇 |
2006年 | 1321篇 |
2005年 | 1215篇 |
2004年 | 1008篇 |
2003年 | 883篇 |
2002年 | 725篇 |
2001年 | 747篇 |
2000年 | 603篇 |
1999年 | 504篇 |
1998年 | 402篇 |
1997年 | 439篇 |
1996年 | 372篇 |
1995年 | 406篇 |
1994年 | 404篇 |
1993年 | 355篇 |
1992年 | 356篇 |
1991年 | 338篇 |
1990年 | 329篇 |
1989年 | 294篇 |
1988年 | 299篇 |
1987年 | 287篇 |
1986年 | 253篇 |
1985年 | 331篇 |
1984年 | 357篇 |
1983年 | 190篇 |
1982年 | 265篇 |
1981年 | 217篇 |
1980年 | 231篇 |
1979年 | 187篇 |
1978年 | 172篇 |
1977年 | 161篇 |
1976年 | 143篇 |
1975年 | 106篇 |
1973年 | 100篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
目的 探讨我国弓形虫Chinese 1优势基因型感染对宿主脑组织铁代谢及脑损伤的影响。方法 将20只C57BL/6(体质量15~17 g)小鼠随机分为对照组和感染组,每组10只。感染组每只小鼠腹腔注射4 000个弓形虫Chinese 1优势基因型TgCtwh3虫株速殖子,对照组小鼠注射等量无菌PBS,饲养6 d后处死小鼠并取其脑组织。采用电感耦合等离子体质谱法(inductively coupled plasma mass spectrometry, ICP⁃MS)检测小鼠脑组织铁元素水平;采用RNA芯片检测两组小鼠脑组织差异基因数目并对功能基因表达情况进行基因本体论(Gene Ontology, GO)功能富集;采用实时荧光定量PCR(fluorescent quantitative real⁃time PCR, qPCR)技术检测小鼠脑组织中弓形虫表面抗原1(Toxoplasma gondii surface antigen 1,TgSAG1)基因及部分锌铁调控蛋白(Zrt⁃ and Irt⁃like protein, ZIP)家族mRNA表达水平;采用光镜和电镜观察小鼠脑组织海马齿轮回(dentate gyrus, DG)超微结构;采用Western blotting检测谷胱甘肽过氧化物酶4(glutathione peroxidase 4, GPx4)蛋白表达水平;采用硫代巴比妥酸(TBA)法检测丙二醛(malondialdehyde, MDA)水平;采用免疫组化检测血管内皮生长因子(vascular endothelial growth factor, VEGF)蛋白表达光密度(optical density, OD)值。结果 光镜下可见感染组小鼠脑组织海马DG区细胞坏死,电镜下见感染组小鼠脑组织海马区出现胞质空泡化、核皱缩坏死、线粒体嵴断裂消融、自噬小体增加等超微结构变化。与对照组相比,感染组小鼠脑组织中铁元素水平上调[(32.92 ± 0.90) µg/g vs.(37.72 ± 1.10) µg/g;t = 3.397, P < 0.01];RNA芯片检测感染组小鼠脑组织发现721个基因上调、276个基因下调,差异表达基因在金属离子结合能力上有明显富集。与对照组相比,感染组小鼠脑组织金属元素转运体ZIP2 mRNA表达水平上调(t = 8.659,P < 0.05)、GPx4表达下降[(1.046 ± 0.025) vs. (0.720 ± 0.101);t = 3.129,P < 0.01])、MDA水平升高[(4.37 ± 0.33) nmol/mgprot vs.(5.93 ± 0.54) nmol/mgprot;t = 2.451,P < 0.05)]、VEGF蛋白平均OD值上调[(0.348 3 ± 0.017 8) vs. (0.490 6 ± 0.010 5);t = 6.641,P < 0.01]。结论 Chinese 1优势基因型弓形虫感染后,小鼠脑组织中铁元素蓄积、抗氧化能力下调、氧化应激水平升高,提示弓形虫感染可影响宿主脑组织铁代谢而导致脑损伤。 相似文献
4.
In the field of drug development, technology for producing human metabolites at a low cost is required. In this study, we explored the possibility of using prokaryotic water-soluble cytochrome P450 (CYP) to produce human metabolites. Streptomyces griseolus CYP105A1 metabolizes various non-steroidal anti-inflammatory drugs (NSAIDs), including diclofenac, mefenamic acid, flufenamic acid, tolfenamic acid, meclofenamic acid, and ibuprofen. CYP105A1 showed 4′-hydroxylation activity towards diclofenac, mefenamic acid, flufenamic acid, tolfenamic acid, and meclofenamic acid. It should be noted that this reaction specificity was similar to that of human CYP2C9. In the case of mefenamic acid, another metabolite, 3′-hydroxymethyl mefenamic acid, was detected as a major metabolite. Substitution of Arg at position 73 with Ala in CYP105A1 dramatically reduced the hydroxylation activity toward diclofenac, flufenamic acid, and ibuprofen, indicating that Arg73 is essential for the hydroxylation of these substrates. In contrast, substitution of Arg84 with Ala remarkably increased the hydroxylation activity towards diclofenac, mefenamic acid, and flufenamic acid. Recombinant Rhodococcus erythrocyte cells expressing the CYP105A1 variant R84A/M239A showed complete conversion of diclofenac into 4′-hydroxydiclofenac. These results suggest the usefulness of recombinant R. erythropolis cells expressing actinomycete CYP, such as CYP105A1, for the production of human drug metabolites. 相似文献
5.
6.
《International journal of medical microbiology : IJMM》2022,312(1):151544
Mycobacterium tuberculosis (M. tuberculosis) encodes an essential enzyme acetyl ornithine aminotransferase ArgD (Rv1655) of arginine biosynthetic pathway which plays crucial role in M. tuberculosis growth and survival. ArgD catalyzes the reversible conversion of N-acetylornithine and 2 oxoglutarate into glutamate-5-semialdehyde and L-glutamate. It also possesses succinyl diaminopimelate aminotransferase activity and can thus carry out the corresponding step in lysine biosynthesis. These essential roles played by ArgD in amino acid biosynthetic pathways highlight it as an important metabolic chokepoint thus an important drug target. We showed that M. tuberculosis ArgD rescues the growth of ΔargD E. coli grown in minimal media validating its functional importance. Phylogenetic analysis of M. tuberculosis ArgD showed homology with proteins in gram positive bacteria, pathogenic and non-pathogenic mycobacteria suggesting the essentiality of this protein. ArgD is a secretory protein that could be utilized by M. tuberculosis to modulate host innate immunity as its moonlighting function. In-silico analysis predicted it to be a highly antigenic protein. The recombinant ArgD protein when exposed to macrophage cells induced enhanced production of pro-inflammatory cytokines TNF, IL6 and IL12 in a dose dependent manner. ArgD also induced the increased production of innate immune effector molecule NOS2 and NO in macrophages. We also demonstrated ArgD mediated activation of the canonical NFkB pathway. Notably, we also show that ArgD is a specific TLR4 agonist involved in the activation of pro-inflammatory signaling for sustained production of effector cytokines. Intriguingly, ArgD protein treatment activated macrophages to acquire the M1 phenotype through the increased surface expression of MHCII and costimulatory molecules CD80 and CD86. ArgD induced robust B-cell response in immunized mice, validating its antigenicity potential as predicted by the in-silico analysis. These properties of M. tuberculosis ArgD signify its functional plasticity that could be exploited as a possible drug target to combat tuberculosis. 相似文献
7.
背景 随着血糖监测技术的发展,近些年来人们开始使用扫描式葡萄糖监测系统(FGMS)"全景式"地观察2型糖尿病(T2DM)患者的血糖水平,明确FGMS指标与T2DM并发症之间的关系有助于提高其临床应用价值,但目前相关研究较少。 目的 探究佩戴FGMS的T2DM患者葡萄糖在目标范围内时间(TIR)等指标与尿白蛋白/肌酐比值(UACR)的相关性。 方法 选取2019年1月至2021年10月于北京大学人民医院老年科就诊并佩戴FGMS的T2DM患者79例,以尿液检查中UACR是否<30 mg/g将患者分为无白蛋白尿组(n=50)和白蛋白尿组(n=29)。比较两组患者的临床特征、实验室检查指标及FGMS指标等。采用Pearson相关、Spearman秩相关分析探讨TIR、高血糖时间(TAR)与糖化血红蛋白(HbA1c)的相关性。分别采用Pearson相关、Spearman秩相关、偏相关分析探讨FGMS指标与lnUACR的相关性。使用多因素Logistic回归分析探究T2DM患者发生白蛋白尿的影响因素,采用受试者工作特征(ROC)曲线评估TIR对白蛋白尿的预测价值。 结果 白蛋白尿组T2DM病程长于无白蛋白尿组,三酰甘油(TG)、HbA1c、平均血糖(MBG)、TAR、平均血糖标准差(SDBG)、最大葡萄糖波动幅度(LAGE)、平均葡萄糖波动幅度(MAGE)、连续每隔2 h血糖净作用(CONGA2)高于无白蛋白尿组,TIR低于无白蛋白尿组(P<0.05)。Pearson相关、Spearman秩相关分析结果显示,TIR与HbA1c呈负相关(P<0.001),TAR与HbA1c呈正相关(P<0.001)。Pearson相关、Spearman秩相关、偏相关分析结果均表明,TIR与lnUACR呈负相关(P<0.001),MBG、TAR、SDBG、LAGE、MAGE、CONGA2与lnUACR呈正相关(P<0.001)。多因素Logistic回归分析结果显示,TIR>70%〔OR=0.038,95%CI(0.003,0.467)〕是T2DM患者出现白蛋白尿的保护因素(P<0.05),TAR升高〔OR=1.046,95%CI(1.000,1.094)〕是T2DM患者出现白蛋白尿的危险因素(P<0.05)。TIR预测T2DM患者出现白蛋白尿的ROC曲线下面积(AUC)为0.784〔95%CI(0.674,0.894)〕(P=0.003),灵敏度为78%,特异度为83%,最佳切点为69.71%。 结论 在FGMS指标中,TIR>70%是T2DM患者出现白蛋白尿的保护因素,TAR升高是T2DM患者出现白蛋白尿的危险因素。同时,SDBG、LAGE、MAGE、CONGA2等多种反映血糖波动的指标也与UACR密切相关。对TIR水平较低及TAR、SDBG、LAGE、MAGE、CONGA2水平较高的T2DM患者进行FGMS筛查有助于早期识别及预防白蛋白尿的发生、发展。 相似文献
8.
Michala G. Rolver Lya K. K. Holland Muthulakshmi Ponniah Nanditha S. Prasad Jiayi Yao Julie Schnipper Signe Kramer Line Elingaard-Larsen Elena Pedraz-Cuesta Bin Liu Luis A. Pardo Kenji Maeda Albin Sandelin Stine Falsig Pedersen 《International journal of cancer. Journal international du cancer》2023,152(8):1668-1684
The mechanisms linking tumor microenvironment acidosis to disease progression are not understood. Here, we used mammary, pancreatic, and colon cancer cells to show that adaptation to growth at an extracellular pH (pHe) mimicking acidic tumor niches is associated with upregulated net acid extrusion capacity and elevated intracellular pH at physiological pHe, but not at acidic pHe. Using metabolic profiling, shotgun lipidomics, imaging and biochemical analyses, we show that the acid adaptation-induced phenotype is characterized by a shift toward oxidative metabolism, increased lipid droplet-, triacylglycerol-, peroxisome content and mitochondrial hyperfusion. Peroxisome proliferator-activated receptor-α (PPARA, PPARα) expression and activity are upregulated, at least in part by increased fatty acid uptake. PPARα upregulates genes driving increased mitochondrial and peroxisomal mass and β-oxidation capacity, including mitochondrial lipid import proteins CPT1A, CPT2 and SLC25A20, electron transport chain components, peroxisomal proteins PEX11A and ACOX1, and thioredoxin-interacting protein (TXNIP), a negative regulator of glycolysis. This endows acid-adapted cancer cells with increased capacity for utilizing fatty acids for metabolic needs, while limiting glycolysis. As a consequence, the acid-adapted cells exhibit increased sensitivity to PPARα inhibition. We conclude that PPARα is a key upstream regulator of metabolic changes favoring cancer cell survival in acidic tumor niches. 相似文献
9.